3Moss AJ, Hall WJ, Cannom DS, et al. Inproved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators[J]. N Engl J Med,1996,335
4The Investigators of the Antiarrhythmics versus Implantable Defibrillators(AVID) Trial. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias[J]. N Engl J Med,1997,337(
5Gradaus R, Block M, Brachmann J, et al. Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results fron the German ICD Registry EURID[J]. Pacing Clin Electrophysiol,2003,26(7 Pt 1):1511-1518.
6Kochiadakis GE, Igoumenidis NE, Hamilos MI, et al. Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation:amiodarone vs propafenone,both in low doses[J]. Chest,2004,125(2):377-383.
7Farshi R, Kismer D, Sarma JS, et al. Ventricuiar rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens[J]. J Am Coll Card,1999,33(2):304-310.
8Guarnieri T, Nolan S, Gottlieb SO, et al. Intravenous amiodarone for the prevention of atrial fibrillation after open-heart surgery:the amiodarone reduction in coronary heart(ARCH)trial[J]. J Am Coll Cardiol,1999,34(2):343-347.
9Volgman AS, Carberry PA. Stambler B, et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation[J]. J Am Coll Cardiol.1998,31(6):1414-1419.
10Varro A, Biliczki P, lost N, et al. Theoretical possibilities for the development of novel antiarrhythmic drugs[J]. Curr Med Chem,2004,11(1):1-11.
